Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency

. 2020 Jan ; 40 (1) : 165-178. [epub] 20191123

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid31760574
Odkazy

PubMed 31760574
DOI 10.1007/s10875-019-00720-6
PII: 10.1007/s10875-019-00720-6
Knihovny.cz E-zdroje

Blau syndrome (BS) is an auto-inflammatory granulomatous disease that possibly involves abnormal response to interferon gamma (IFNγ) due to exaggerated nucleotide-binding oligomerization domain containing 2 (NOD2) activity. Mendelian susceptibility to mycobacterial diseases (MSMD) is an infectious granulomatous disease that is caused by impaired production of or response to IFNγ. We report a mother and daughter who are both heterozygous for NOD2c.2264C˃T variant and dominant-negative IFNGR1818del4 mutation. The 17-year-old patient displayed an altered form of BS and milder form of MSMD, whereas the 44-year-old mother was completely asymptomatic. This experiment of nature supports the notion that IFNγ is an important driver of at least some BS manifestations and that elucidation of its involvement in the disease immunopathogenesis may identify novel therapeutic targets.

Zobrazit více v PubMed

Bioinformatics. 2009 Jul 15;25(14):1754-60 PubMed

Blood. 2005 Feb 1;105(3):1195-7 PubMed

J Leukoc Biol. 2015 Jun;97(6):1111-9 PubMed

Semin Immunol. 2014 Dec;26(6):454-70 PubMed

Nat Genet. 2001 Sep;29(1):19-20 PubMed

J Biol Chem. 2003 Mar 14;278(11):8869-72 PubMed

Nat Rev Immunol. 2014 Jan;14(1):9-23 PubMed

Ocul Immunol Inflamm. 2018;26(1):57-64 PubMed

J Inflamm Res. 2018 Feb 12;11:49-60 PubMed

J Am Acad Dermatol. 2003 May;48(5 Suppl):S99-102 PubMed

Reumatismo. 2015 Mar 31;66(4):277-84 PubMed

Gastroenterology. 2003 Apr;124(4):1001-9 PubMed

J Allergy Clin Immunol. 2012 Apr;129(4):1076-84 PubMed

Arthritis Rheum. 2009 Jan;60(1):242-50 PubMed

Immunol Rev. 2019 Jan;287(1):33-49 PubMed

Turk J Pediatr. 2016;58(5):545-549 PubMed

Pediatr Rheumatol Online J. 2014 Aug 06;12:33 PubMed

Clin Immunol. 2014 Mar;151(1):25-8 PubMed

Pediatr Dermatol. 2016 Nov;33(6):e385-e387 PubMed

N Engl J Med. 1996 Dec 26;335(26):1941-9 PubMed

Arthritis Rheum. 2009 Jun;60(6):1797-803 PubMed

Immunol Rev. 2005 Feb;203:38-47 PubMed

Pediatrics. 2001 Apr;107(4):E48 PubMed

J Allergy Clin Immunol. 2018 Jan;141(1):339-349.e11 PubMed

Sci Immunol. 2018 Dec 21;3(30): PubMed

J Pediatr. 1999 Nov;135(5):543-5 PubMed

J Immunol. 2015 Jan 1;194(1):349-57 PubMed

Blood. 1991 Dec 1;78(11):2918-22 PubMed

Nat Genet. 1999 Apr;21(4):370-8 PubMed

Rheumatology (Oxford). 2010 Jan;49(1):194-6 PubMed

Immunol Cell Biol. 2019 Apr;97(4):360-367 PubMed

PLoS Genet. 2006 Aug 18;2(8):e131 PubMed

Arthritis Rheum. 2009 Jun;60(6):1804-6 PubMed

PLoS Pathog. 2005 Nov;1(3):279-85 PubMed

Cell Physiol Biochem. 2012;30(4):953-63 PubMed

Nat Immunol. 2018 Sep;19(9):973-985 PubMed

Front Genet. 2012 Mar 15;3:35 PubMed

Cell Microbiol. 2011 Mar;13(3):402-18 PubMed

Semin Immunol. 2006 Dec;18(6):347-61 PubMed

Arthritis Rheum. 2009 Feb;60(2):611-8 PubMed

J Clin Invest. 1997 Dec 1;100(11):2658-64 PubMed

J Pathol. 1997 Jan;181(1):25-30 PubMed

Curr Opin Rheumatol. 2011 Sep;23(5):411-8 PubMed

Sci Immunol. 2018 Dec 21;3(30): PubMed

Lancet. 2002 Apr 20;359(9315):1393-401 PubMed

Rheumatol Int. 2010 Jun;30(8):1121-4 PubMed

Lancet. 2004 Dec 11-17;364(9451):2113-21 PubMed

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42 PubMed

Genome Res. 2012 Mar;22(3):568-76 PubMed

Rheumatology (Oxford). 2015 Jun;54(6):1008-16 PubMed

Bioinformatics. 2009 Aug 15;25(16):2078-9 PubMed

J Clin Invest. 2013 Oct;123(10):4142-3 PubMed

Hum Mol Genet. 2018 Nov 15;27(22):3919-3935 PubMed

J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946 PubMed

Science. 2007 Sep 14;317(5844):1522-7 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...